MD Anderson Madrid – Hospiten acquires 3-Tesla Magnetic Resonance equipment capable of mapping brain functions like speech and movement Published on 28/05/2019 In addition to higher-resolution images, this technology reduces image noise and the time needed to carry out the procedure, resulting in a less stressful experience for the patient
MD Anderson Madrid – Hospiten brings emotion to CIBECOM’2019 Published on 10/05/2019 The II Ibero-American Summit on Strategic Communication (CIBECOM), held May 8 - 10 in Madrid, is the main international event for Spanish and Portuguese speaking executives to find solutions and to learn about the latest trends in communication that make their organizations grow
Knowing what a cancer patient is facing is essential to recovery Published on 12/04/2019 According to data from the Spanish Society of Medical Oncology (SEOM), it is estimated that this year more than 270,000 new cases of cancer will be diagnosed in Spain, a number that increases every year. Of these, almost half will be in women, who will mostly be diagnosed with breast, colon or gynecological cancer (cervix, uterus or ovary). As a patient, facing the news of a cancer diagnosis can be shocking, even devastating, and there will be many questions - will I get through this? Will I have physical aftereffects? Will the treatment work or will it be a waste of time?
MD Anderson Madrid – Hospiten lends excitement to CIBECOM’2019 Published on 08/04/2019 The talk, "Managing emotions in situations of critical communication", seeks to help attendees identify, analyze and manage their own emotions so that these do not interfere in the professional field.
MD Anderson Cancer Center Madrid – Hospiten is awarded the ‘Premio Puente’ for its work fomenting and facilitating relations between Spain and the United States. Published on 18/03/2019 Nuria Gonzalez, General Manager and Dr. Santiago Gonzalez Moreno, Medical Director of MD Anderson Cancer Center Madrid – Hospiten, accepted the award from the American Club of Madrid
The first surgical treatment in endometriosis affects the disease’s long-term prognosis Published on 13/03/2019 Patients who have undergone adequate surgery for endometriosis may relapse in 15% of cases, whereas 80% of relapse cases occur when surgery is partial
Marking small intra-abdominal lesions of difficult access with iodine seeds helps guide doctors and facilitates their removal Published on 25/02/2019
Vaporized chemotherapy administered intraperitoneally offers hopeful results in patients with metastases in the area Published on 11/02/2019 The administration of pressurized intraperitoneal aerosol chemotherapy (PIPAC) offers new treatment options for patients with peritoneal carcinomatosis, that is, with metastases in the peritoneum, who are not candidates for curative surgical treatment. "Intravenous systemic chemotherapy is the standard treatment in patients with advanced cancer which cannot be completely removed due to the great volume of the disease," says Dr. Gloria Ortega, of the Surgical Oncology Service of MD Anderson Madrid – Hospiten. "The problem is that patients in treatment with systemic chemotherapy begin to have numerous complications derived from the treatment," specialist goes on, who points out that PIPAC is treatment that, while used in combination with systemic chemotherapy, "allows the disease to be controlled with fewer adverse effects".
The opinion of surgical oncology, vital to the multidisciplinary committees that determine the best treatment plan for a cancer patient Published on 04/02/2019
A new surgical technique allows better visualization and more precise resection of rectal tumors near the anus Published on 23/01/2019 Total mesorectal excision, that is, the removal of the rectum and surrounding fat and lymph nodes, is the standard treatment for rectal cancer - an effective approach that can be performed by laparotomy (open surgery), laparoscopy or robot-assisted surgery. The problem with this approach is "the lack of clear vision of the most distal part of the rectum, which makes complete resection of the tumor difficult", explains Dr. Oscar Alonso, a specialist in gastrointestinal surgical oncology at MD Anderson Madrid – Hospiten. Therefore, the closer the tumor is to the anus, the more difficult it is to see and more likely the resection is to be incomplete and with tumor recurrence.